Troxerutin

曲克芦丁

Report date: 2023/03/09 20:00:36
NME

Base Information

Drug NameTroxerutin
Drug Alias Name三羟乙基芦丁Veinamitol维脑路通Vitamin-P4Vastribil +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)HemorrhageBlood Coagulation Disorders +[7] 
Global Approved IndicationsHemorrhageThrombophlebitisArterial Occlusive Diseases +[4] 
Approved Indications in ChinaHemorrhageThrombophlebitisArterial Occlusive Diseases +[4] 
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesWestlake UniversityHpgc Renmintongtai Pharmaceutical Co
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)HemorrhageBlood Coagulation Disorders +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeC05CA04
Related LinksWikipediaKEGG